U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Tue Mar 06 10:33:36 UTC 2018
Edited
by admin
on Tue Mar 06 10:33:36 UTC 2018
Protein Sub Type
Sequence Origin HUMAN
Sequence Type COMPLETE
Record UNII
50U1BO5G5P
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ALPHA-2A ADRENERGIC RECEPTOR
Common Name English
ALPHA-2AAR
Common Name English
ALPHA-2A ADRENORECEPTOR
Common Name English
ALPHA-2 ADRENERGIC RECEPTOR SUBTYPE C10
Common Name English
ADRA2A
Common Name English
Code System Code Type Description
PHAROS
P08913
Created by admin on Tue Mar 06 10:33:36 UTC 2018 , Edited by admin on Tue Mar 06 10:33:36 UTC 2018
PRIMARY
WIKIPEDIA
ALPHA-2_ADRENERGIC_RECEPTOR#INDIVIDUAL
Created by admin on Tue Mar 06 10:33:36 UTC 2018 , Edited by admin on Tue Mar 06 10:33:36 UTC 2018
PRIMARY
UNIPROT
P08913
Created by admin on Tue Mar 06 10:33:36 UTC 2018 , Edited by admin on Tue Mar 06 10:33:36 UTC 2018
PRIMARY
From To
1_106 1_188
Glycosylation Type HUMAN
Glycosylation Link Type Site
N 1_10
N 1_14
Related Record Type Details
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING
AGONIST -> TARGET
SHORT-ACTING

Structural Modifications

Modification Type Location Site Location Type Residue Modified Extent Fragment Name Fragment Approval
AMINO ACID SUBSTITUTION [1_331] DEXFOSFOSERINE VI4F0K069V
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT CHEMICAL